ATE300958T1 - Stabilisierte vitamin c formulierungen - Google Patents

Stabilisierte vitamin c formulierungen

Info

Publication number
ATE300958T1
ATE300958T1 AT00936442T AT00936442T ATE300958T1 AT E300958 T1 ATE300958 T1 AT E300958T1 AT 00936442 T AT00936442 T AT 00936442T AT 00936442 T AT00936442 T AT 00936442T AT E300958 T1 ATE300958 T1 AT E300958T1
Authority
AT
Austria
Prior art keywords
glycol
ascorbic acid
formulations
mixed
stabilizing
Prior art date
Application number
AT00936442T
Other languages
English (en)
Inventor
Rajiv Mathur
Original Assignee
Igen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igen Inc filed Critical Igen Inc
Application granted granted Critical
Publication of ATE300958T1 publication Critical patent/ATE300958T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT00936442T 1999-06-10 2000-05-31 Stabilisierte vitamin c formulierungen ATE300958T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/329,608 US6087393A (en) 1999-06-10 1999-06-10 Stabilized vitamin C formulations
PCT/US2000/015061 WO2000076547A1 (en) 1999-06-10 2000-05-31 Stabilized vitamin c formulations

Publications (1)

Publication Number Publication Date
ATE300958T1 true ATE300958T1 (de) 2005-08-15

Family

ID=23286209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936442T ATE300958T1 (de) 1999-06-10 2000-05-31 Stabilisierte vitamin c formulierungen

Country Status (7)

Country Link
US (2) US6087393A (de)
EP (1) EP1194169B1 (de)
AT (1) ATE300958T1 (de)
AU (1) AU5175700A (de)
CA (1) CA2376303C (de)
DE (1) DE60021727D1 (de)
WO (1) WO2000076547A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074396A1 (en) 2000-04-04 2001-10-11 Amarillo Biosciences, Inc. Composition and method for promoting oral health
DE60111362T2 (de) 2000-09-08 2006-07-20 Vivier Canada Inc., Vaudreuil Stabilisierte ascorbinsäure-lösungen
KR100836032B1 (ko) * 2002-03-26 2008-06-09 (주)아모레퍼시픽 Ｌ-아스코빌산 함유 다중공 고분자 마이크로캡슐, 이의제조방법 및 이를 함유하는 화장료 조성물
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
US20070077261A1 (en) * 2005-10-03 2007-04-05 Jerry Zhang Compositions and method for enhancing the solubility of ascorbic acid using solubilization enhancers
JP2007161635A (ja) * 2005-12-13 2007-06-28 Kanebo Ltd 二層分離型化粧料
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US7786055B2 (en) * 2006-04-13 2010-08-31 Mcneil-Ppc, Inc. Antioxidant compositions for reducing odor in warming lubricant compositions
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
GB201013680D0 (en) * 2010-08-14 2010-09-29 Chatfield Pharmaceuticals Ltd Stable vitamin c formulations
JP5627104B2 (ja) * 2011-02-04 2014-11-19 Ｍｔコスメティクス株式会社 アスコルビン酸を配合した溶液及びその溶液の製造方法
DE102013018573A1 (de) 2013-10-31 2015-05-21 Stephan Teichmann Oxidationsstabile Zubereitung
US20170239250A1 (en) 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
TWI887200B (zh) * 2018-03-30 2025-06-21 日商樂敦製藥股份有限公司 含有抗壞血酸以及/或是其鹽的外用組成物、以及防止外用組成物之著色以及/或是結晶之析出之方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES355628A1 (es) * 1967-06-30 1969-12-16 Hoffmann La Roche Procedimiento para la estabilizacion de acido ascorcibo y sus derivados.
JPS53127819A (en) * 1977-04-12 1978-11-08 Riken Vitamin Co Ltd Stabilization of l-asocorbic acid and its salt
US4983392A (en) 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
DE3814839A1 (de) * 1988-05-02 1989-11-16 Henkel Kgaa Haarbehandlungsmittel mit natuerlichen inhaltsstoffen
US5140043A (en) * 1989-04-17 1992-08-18 Duke University Stable ascorbic acid compositions
FR2715844B1 (fr) * 1994-02-04 1996-03-29 Oreal Emulsion contenant de l'acide ascorbique stabilisé, procédé de traitement cosmétique la mettant en Óoeuvre, ses utilisations.
US5587149A (en) * 1995-02-06 1996-12-24 R.P. Scherer Corporation Topical application emulsions
US5843411A (en) * 1997-02-06 1998-12-01 Topix Pharmaceuticals Inc. Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
US5853741A (en) 1996-06-28 1998-12-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Vitamin C delivery system
US6162419A (en) 1996-11-26 2000-12-19 Nicholas V. Perricone Stabilized ascorbyl compositions

Also Published As

Publication number Publication date
US6211231B1 (en) 2001-04-03
CA2376303C (en) 2008-07-29
EP1194169B1 (de) 2005-08-03
CA2376303A1 (en) 2000-12-21
EP1194169A1 (de) 2002-04-10
US6087393A (en) 2000-07-11
WO2000076547A1 (en) 2000-12-21
DE60021727D1 (de) 2005-09-08
AU5175700A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
DE60021727D1 (de) Stabilisierte vitamin c formulierungen
MXPA02012817A (es) Drogas antineoplasicas liposomales y uso de las mismas.
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
IL144026A0 (en) Phenylphenanthridine derivatives and pharmaceutical compostions containing the same
ATE256681T1 (de) N-heterozyklische derivate als nos inhibitoren
IL140710A0 (en) Pulmonary delivery of active agents
DE69836422D1 (de) N-heterocyclische derivate als nos inhibitoren
PT1128812E (pt) Nanoemulsao de acido 5-aminolevulinico
IS6658A (is) Ný efnasambönd
EP1226109A4 (de) Phenylamin-carbonsäure-verbindungen und zubereitungen zur verabreichung von wirkstoffen
BR0302672A (pt) Formulação farmacêutica nutriente compreendendo polifenóis e seus usos no tratamento de câncer
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ZA200410109B (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability.
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
MXPA05013278A (es) Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
ATE297188T1 (de) Stabilisierte ascorbinsäure-lösungen
IT1271456B (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
HRP20020844B1 (hr) Tekuće formulacije
MY114944A (en) Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use
EP1339710A4 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
AU2668800A (en) Mixture of plant-treatment agents and waxes, method for producing same and the use thereof
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
SE9902742D0 (sv) New pharmaceutical formultion
EP1321141A4 (de) Vitamin d3-enthaltende inhibitoren der parathyroidhormonproduktion
EP1322315A4 (de) Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties